Landscapes / Companies

Guerbet not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
 
Next date
gadopiclenol, Phase 3 trial completes
Drugs
2
in active trials · 10 in all
Trials
2 active
14 since 2021

Drugs2

DrugHow it worksPartnerStageNext dateDetails
—
Approved 31 Dec 2027Phase 3 trial completes
Gadolinium-based contrast agent
Approved 31 Dec 2027Phase 3 trial completes

About

No active trial
8 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021

Follow Guerbet

Following is part of Solo: you see every change to Guerbet the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in